What is the Bal Pharma Ltd share price today?

The share price of NSE:BALPHARMA-EQ on 01 Oct 2026 (as of 15:03:09 IST) is ₹105.59.

What is the NSE:BALPHARMA-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:BALPHARMA-EQ 52 week high low range shows a high of ₹124.6 and a low of ₹60.

What is the Bal Pharma Ltd market cap?

As on 01 Oct 2026, Bal Pharma Ltd market cap is ₹1739830000.

What is the shareholding pattern of Bal Pharma Ltd Stock?

The shareholding pattern of Bal Pharma Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 50.86% Foreign Institutional Investors (FII): 0.15% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 48.99% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Bal Pharma Ltd?

The Price-to-Earnings (PE) ratio of Bal Pharma Ltd is 24.1375, and the Price-to-Book (PB) ratio is 1.1644, as on 01 Oct 2026.

Bal Pharma Share Price

81.80+0.99 (+1.23%)

-0.90% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

+1.23%

1 Week

-0.06%

1 Month

-23.40%

3 Month

-5.86%

6 Month

+2.06%

YTD

+11.57%

1 Year

-0.90%

5 Year

-15.84%

10 Year

-24.12%

Max

+27.91%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

81.10

79.20

77.60

75.10

60.00

High

84.45

105.00

124.60

About

No results found

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

No results found

Bal Pharma Share Price

81.80+0.99 (+1.23%)

-0.90% past 1 Year

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Bal Pharma Share Price

81.80+0.99 (+1.23%)

-0.90% past 1 Year

Financial overview

Peer Comparison

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Balance Sheet

Consolidated

Standalone

₹

%

Cash Flow

Consolidated

Standalone

₹

%

Fundamental Ratios

Consolidated

Standalone

Bal Pharma Share Price

81.80+0.99 (+1.23%)

-0.90% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Bal Pharma Share Price

81.80+0.99 (+1.23%)

-0.90% past 1 Year

Shareholding summary

No data available

Promoters

—

FII

—

DII

—

MF

—

Others

—

Promoters

FII

DII

MF

Others

Quarterly

Yearly

No data available

Shareholding Pattern

Quarterly

Yearly

No results found

Bulk & block deals

No results found

Insider trading & SAST

4 Nov 2026

India Services PMI Signals Continued Expansion In October

Broader Market

4 Nov 2026

Equity

GARUDA

4 Nov 2026

Bal Pharma Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Bal Pharma Share Price

Bal Pharma Share Price

Financial overview

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Bal Pharma Share Price

Bal Pharma Share Price

Bal Pharma Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Bal Pharma Share Price

Corporate Actions

Company details

Bal Pharma Share Price

Corporate filings & documents

Bal Pharma Share Price

News

Vincofe Reports Stronger Second Quarter EBITDA Growth And Margin Expansion

Vincofe Reports Strong Second Quarter Revenue Growth Year On Year

Vincofe Q2 Consolidated Net Profit Rises 57.9 Percent Year On Year

NAM India Reports Rs 59.36 Crores BSE Block Trade At Rs 991

Petronet LNG Reports Rs 31 Crores BSE Block Trade

Tata Power Faces FIR Over Alleged Rs 4,800 Crore Russian Coal Licence Fraud

Allied Blenders Reports Record Festive Season Monthly Sales Volumes

Tata Power Faces Unverified Rs 4,800 Crore Compensation Claim

Concord Enviro Cuts FY27 Revenue Growth and EBITDA Margin Guidance

India Services PMI Signals Continued Expansion In October

India October Composite PMI Signals Continued Private Sector Expansion

Gaja Reports Strong Year On Year Growth In Second Quarter Consolidated Net Profit

Bharat Forge North America Truck Orders Decline Sharply In October

Sun Pharma Clarifies Eye Care Production Halt Linked To Quality Issues

Metropolis Guides For FY27 EBITDA Margin Expansion On Pricing And Platform Completion

Solar Industries Expects To Surpass FY27 Revenue And EBITDA Guidance

Solar Industries Pinaka Orders May Generate Rs 2,600 Crore Inflows

Garuda Construction Q2 Revenue Rises Sharply Year On Year

Garuda Construction Reports Higher Second Quarter EBITDA And Margin

Garuda Construction Reports Strong Second Quarter Net Profit Growth

Bal Pharma Ltd Share Price Today

Bal Pharma Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator